Search
Search Results
-
Safety and feasibility of pulmonary vein isolation utilizing pulsed field ablation in patients with symptomatic atrial fibrillation and implanted Watchman devices
BackgroundPulsed field ablation (PFA) is a novel method of non-thermal cardiac ablation for atrial fibrillation (AF). Its use on patients with...
-
Feasibility of contrast-free left atrial appendage closure with WATCHMAN FLX device for patients with chronic kidney disease
Contrast media are generally necessary for transcatheter left atrial appendage closure (LAAC), however, it should be avoided in patients with chronic...
-
Left Atrial Appendage Closure with Watchman vs Amulet Devices: Similarities and Differences
Purpose of ReviewLeft atrial appendage closure (LAAC) has shown to be non-inferior to oral anticoagulation (OAC) for non-valvular atrial fibrillation...
-
Peri-device leakage and delayed endothelialization of the Watchman device: a computed tomography study
ObjectivesThis study aimed to explore the endothelialization process and assess the potential association between endothelialization and peri-device...
-
Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
BackgroundThe left atrial appendage (LAA) sealing properties of the Amplatzer Amulet and Watchman FLX devices were compared using cardiac computed...
-
Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)
BackgroundVarious randomized multicenter studies have shown that percutaneous left atrial appendage closure (LAAC) is not inferior in stroke...
-
-
-
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure
Residual or newly acquired leaks are routinely appraised after left atrial appendage closure (LAAC). The Watchman and the Amulet are the two most...
-
Left atrial appendage closure with the watchman device reduces atrial fibrillation management costs
AimsTo report hospitalization costs of patients with non-valvular atrial fibrillation (AF) submitted to percutaneous left atrial appendage closure...
-
The prevalence and characteristics of candidates for percutaneous left atrial appendage occlusion using a WATCHMAN device among patients who underwent atrial fibrillation ablation in a Japanese population
BackgroundPercutaneous left atrial appendage occlusion (LAAO) using a WATCHMAN device could be a treatment option for patients with non-valvular...
-
Outcomes in patients implanted with a Watchman device in relation to choice of anticoagulation and indication for implant
BackgroundPatients with atrial fibrillation are increasingly prescribed a direct oral anticoagulant (DOAC) over warfarin and seek to avoid...
-
Detailed thrombogenicity phenoty** and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case–control study
The relation of device related thrombosis (DRT) and major bleeding after left atrial appendage closure (LAAC) to laboratory thrombosis and hemostasis...
-
Watchman outcomes comparing post-implantation anticoagulation with warfarin versus direct oral anticoagulants
PurposeAs left atrial appendage occlusion devices (LAAO) implantation rates grow, continued evaluation on best patient practices is important. We...
-
Reactive atrial-based anti-tachycardia pacing algorithm in cardiovascular implantable electronic devices is safe and feasible without increase in thromboembolic events in patients with a left atrial appendage closure device
BackgroundReactive atrial-based anti-tachycardia pacing (rATP) in CIED (cardiovascular implantable electronic devices) is effective in atrial...
-
WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage
PurposeUse of oral anticoagulation (OAC) in patients with a history of intracranial hemorrhage (ICH) is often considered high risk as OAC-related ICH...
-
Validation study of new left atrial appendage closure device measurement by two-dimensional and three-dimensional transesophageal echocardiography
BackgroundIn left atrial appendage closure using WATCHMAN FLX, accurate device measurement by transesophageal echocardiography (TEE) is important. We...
-
Percutaneous Left Atrial Appendage Closure: Review of Anatomy, Imaging, and Outcomes
Purpose of reviewPercutaneous left atrial appendage closure (LAAC) with WATCHMAN (Boston Scientific Inc.) has emerged as a viable non-pharmacological...
